Wednesday - April 08, 2026

Category Archives: Science

Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Influenza Pipeline Insight 2026” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the Influenza pipeline landscape. It covers the Influenza Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Influenza Pipeline … Continue reading →

Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Hepatitis B Virus Infection Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus (HBV) Infection pipeline landscape. It covers the Hepatitis B Virus Infection pipeline drug profiles, including clinical and … Continue reading →

Herpes Zoster Treatment Market Size in the 7MM is projected to increase at a significantly CAGR by 2036, estimates DelveInsight

DelveInsight’s “Herpes Zoster Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Herpes Zoster, historical and forecasted epidemiology as well as the Herpes Zoster market trends in the United States, EU5 (Germany, Spain, Italy, France, and … Continue reading →

Opioid Use Disorder Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Opioid Use Disorder Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Opioid Use Disorder pipeline landscape. It covers the Opioid Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Knee Osteoarthritis Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Knee Osteoarthritis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Knee Osteoarthritis pipeline landscape. It covers the Knee Osteoarthritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

BK Virus Infection Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “BK Virus Infection Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in BK Virus Infection pipeline landscape. It covers the BK Virus Infection pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Postpartum Depression Clinical Trial Pipeline Shows Potential with Active Contributions from 10+ Key Companies | DelveInsight

DelveInsight’s, “Postpartum Depression Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Postpartum Depression pipeline landscape. It covers the Postpartum Depression pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Liver Fibrosis Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Liver Fibrosis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Liver Fibrosis pipeline landscape. It covers the Liver Fibrosis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →